| 697908 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures |
2021-06-01 |
10.1136/jitc-2021-002345 |
Cheung Laurene S, Chen Lingling, Oke Teniola F, Schaffer Thomas B, Boudadi Karim, Ngo Jillian T, Gross John McMahon, Kemberling Holly, Diaz Luis A, Lipson Evan, Sidhom John-WIlliam, Taube Janis, Anders Robert, Pardoll Drew M, Le Dung T, Meyer Christian F, Llosa Nicolas |
| 697907 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy |
2021-06-01 |
10.1136/jitc-2020-002157 |
Niogret Julie, Berger Hélène, Rebe Cédric, Mary Romain, Ballot Elise, Truntzer Caroline, Thibaudin Marion, Derangère Valentin, Hibos Christophe, Hampe Léa, Rageot David, Accogli Théo, Joubert Philippe, Routy Bertrand, Harker James, Vegran Frederique, Ghiringhelli Francois, Chalmin Fanny |
| 697906 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients |
2021-06-01 |
10.1136/jitc-2021-002512 |
Gérard Alexandre, Doyen Jerome, Cremoni Marion, Bailly Laurent, Zorzi Kevin, Ruetsch-Chelli Caroline, Brglez Vesna, Picard-Gauci Alexandra, Troin Laura, Esnault Vincent L.M., Passeron Thierry, Montaudié Henri, Seitz-Polski Barbara |
| 697905 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors |
2021-06-01 |
10.1136/jitc-2021-002344 |
Hurkmans Daan P., Sassen Sebastiaan D.T., de Joode Karlijn, Putter Lisanne, Basak Edwin A., Wijkhuijs Annemarie J.M., Joerger Markus, Debets Reno, Koch Birgit C.P., Van der Leest Cor H., Schreurs Marco W.J., van der Veldt Astrid A.M., Aerts Joachim G.J.V., Mathijssen Ron H.J., Koolen Stijn L.W. |
| 697904 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial |
2021-06-01 |
10.1136/jitc-2021-002568 |
Ferris Robert L, Spanos William C, Leidner Rom, Gonçalves Anthony, Martens Uwe M, Kyi Chrisann, Sharfman William, Chung Christine H, Devriese Lot A, Gauthier Helene, Chiosea Simon I, Vujanovic Lazar, Taube Janis M, Stein Julie E, Li Jun, Li Bin, Chen Tian, Barrows Adam, Topalian Suzanne L |
| 697903 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide |
2021-06-01 |
10.1136/jitc-2021-002544 |
Shenderov Eugene, Kandasamy Matheswaran, Gileadi Uzi, Chen Jili, Shepherd Dawn, Gibbs James, Prota Gennaro, Silk Jonathan D, Yewdell Jonathan W, Cerundolo Vincenzo |
| 697902 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial |
2021-06-01 |
10.1136/jitc-2020-002255 |
Antill Yoland, Kok Peey-Sei, Robledo Kristy, Yip Sonia, Cummins Michelle, Smith Deborah, Spurdle Amanda, Barnes Elizabeth, Lee Yeh Chen, Friedlander Michael, Baron-Hay Sally, Shannon Catherine, Coward Jermaine, Beale Philip, Goss Geraldine, Meniawy Tarek, Lombard Janine, Andrews John, Stockler Martin R, Mileshkin Linda |
| 697901 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma |
2021-06-01 |
10.1136/jitc-2020-002273 |
Lynch Kevin T, Young Samuel J, Meneveau Max O, Wages Nolan A, Engelhard Victor H, Slingluff Jr Craig L, Mauldin Ileana S |
| 697900 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Direct and indirect immune effects of CMP-001, a virus-like particle containing a TLR9 agonist |
2021-06-01 |
10.1136/jitc-2021-002484 |
Sabree Shakoora A, Voigt Andrew P, Blackwell Sue E, Vishwakarma Ajaykumar, Chimenti Michael S, Salem Aliasger K, Weiner George J |
| 697899 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Targeting cancer testis antigens in synovial sarcoma |
2021-06-01 |
10.1136/jitc-2020-002072 |
Mitchell Geoffrey, Pollack Seth M, Wagner Michael J |
